Urinary Bladder Diseases

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2015-04-01
Clinical Trial Update: SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study I [Phase 3]
Phase 3 trial SHTC EUROPE-1 evaluating Synergo hyperthermia-chemotherapy for urinary bladder neoplasms has been withdrawn.